(Q48940326)

17 February 2018

title

Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. (English)

1 reference

17 February 2018

0 references

0 references

Roher AE

1

1 reference

17 February 2018

Chaney MO

2

1 reference

17 February 2018

Kuo YM

3

1 reference

17 February 2018

Webster SD

4

1 reference

17 February 2018

Stine WB

5

1 reference

17 February 2018

Haverkamp LJ

6

1 reference

17 February 2018

Woods AS

7

1 reference

17 February 2018

Cotter RJ

8

1 reference

17 February 2018

Tuohy JM

9

1 reference

17 February 2018

Krafft GA

10

1 reference

17 February 2018

Bonnell BS

11

1 reference

17 February 2018

Emmerling MR

12

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 August 1996

1 reference

17 February 2018

Journal of Biological Chemistry

published in

1 reference

17 February 2018

volume

271

1 reference

17 February 2018

issue

34

1 reference

17 February 2018

page(s)

20631-20635

1 reference

17 February 2018

Amyloid beta-protein and the genetics of Alzheimer's disease

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Amyloid beta-peptide is produced by cultured cells during normal metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Soluble amyloid beta-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Alzheimer's disease and soluble A beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Biochemical evidence for the long-tail form (A beta 1-42/43) of amyloid beta protein as a seed molecule in cerebral deposits of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Modified amyloid beta protein ending at 42 or 40 with different solubility accumulates in the brain of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Morphological and biochemical analyses of amyloid plaque core proteins purified from Alzheimer disease brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Cytotoxicity of microglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Characterization of beta-amyloid peptide from human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Morphological study of amyloid fibrils and preamyloid deposits in the brain with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Phagocytosis of myelin by astrocytes in explants of adult rabbit cerebral white matter maintained on Gelfoam matrix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Synthesis and release of neuroactive substances by glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

Inflammation and Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.34.20631

21 January 2018

Identifiers

DOI

10.1074/JBC.271.34.20631

1 reference

17 February 2018

PubMed ID

8702810

1 reference

17 February 2018